Treatment of slowly growing mycobacteria

Clin Chest Med. 2015 Mar;36(1):79-90. doi: 10.1016/j.ccm.2014.10.005. Epub 2014 Nov 6.

Abstract

The most common nontuberculous mycobacterial (NTM) lung pathogen, Mycobacterium avium complex (MAC), requires antibiotic treatment regimens that are long and often arduous. M kansasii is the slowly growing NTM pathogen with the most predictably successful treatment outcomes, whereas other slowly growing NTM pathogens such as M xeonpi, M szulgai, and M malmoense are less predictably responsive to antibiotic regimens. M simiae is the most difficult of the common slowly growing NTM pathogens to eradicate. Surgical intervention for slowly growing mycobacterial lung infection has proved beneficial for some patients, but the optimal candidates and timing for surgical intervention remain unknown.

Keywords: Bronchiectasis; M avium; MAC; Mycobacterial disease; Mycobacterium avium complex; NTM; Nontuberculous mycobacteria; Slow-growing mycobacteria.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Drug Resistance, Bacterial*
  • Humans
  • Lung Diseases / drug therapy*
  • Lung Diseases / microbiology
  • Mycobacterium Infections, Nontuberculous / drug therapy*
  • Mycobacterium Infections, Nontuberculous / microbiology
  • Nontuberculous Mycobacteria / drug effects*
  • Nontuberculous Mycobacteria / pathogenicity
  • Prognosis

Substances

  • Anti-Bacterial Agents